Literature DB >> 9473227

Ligneous conjunctivitis in plasminogen-deficient mice.

A F Drew1, A H Kaufman, K W Kombrinck, M J Danton, C C Daugherty, J L Degen, T H Bugge.   

Abstract

Ligneous conjunctivitis is a rare form of chronic pseudomembranous conjunctivitis that is associated with systemic membranous pathological changes. A probable link between plasminogen and ligneous conjunctivitis has been indicated by the recent diagnoses of plasminogen deficiency in five patients suffering from ligneous conjunctivitis. The current study reports that plasminogen-deficient mice develop conjunctival lesions indistinguishable from human ligneous conjunctivitis in both appearance and histology. Both human and mouse lesions contain acellular material rich in fibrin, and aberrant or disrupted epithelium. The incidence of lesion development in mice increases with age and is strongly influenced by genetic background. Interestingly, ligneous conjunctivitis was not observed in plasminogen-deficient mice simultaneously lacking fibrinogen. This study provides direct evidence that plasminogen deficiency is one cause of ligneous conjunctivitis and suggests that plasminogen-deficient mice may be an excellent model for the development of therapeutic strategies for the treatment of this debilitating disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9473227

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

1.  Ligneous conjunctivitis: biochemical evidence for hypofibrinolysis.

Authors:  M L Ramsby; P C Donshik; G S Makowski
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

2.  Ligneous conjunctivitis: a clinicopathological, immunohistochemical, and genetic study including the treatment of two sisters with multiorgan involvement.

Authors:  M Teresa Rodríguez-Ares; Ihab Abdulkader; Ana Blanco; Rosario Touriño-Peralba; Clara Ruiz-Ponte; Ana Vega; José Cameselle-Teijeiro
Journal:  Virchows Arch       Date:  2007-08-15       Impact factor: 4.064

3.  Plasminogen activators direct reorganization of the liver lobule after acute injury.

Authors:  J A Bezerra; A R Currier; H Melin-Aldana; G Sabla; T H Bugge; K W Kombrinck; J L Degen
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

4.  Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.

Authors:  N Hattori; J L Degen; T H Sisson; H Liu; B B Moore; R G Pandrangi; R H Simon; A F Drew
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

5.  Plasminogen deficiency leads to impaired remodeling after a toxic injury to the liver.

Authors:  J A Bezerra; T H Bugge; H Melin-Aldana; G Sabla; K W Kombrinck; D P Witte; J L Degen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

6.  Plasminogen-receptor KT : plasminogen activation and beyond.

Authors:  M J Flick; T H Bugge
Journal:  J Thromb Haemost       Date:  2016-11-25       Impact factor: 5.824

Review 7.  New insights into the role of Plg-RKT in macrophage recruitment.

Authors:  Lindsey A Miles; Shahrzad Lighvani; Nagyung Baik; Caitlin M Parmer; Sophia Khaldoyanidi; Barbara M Mueller; Robert J Parmer
Journal:  Int Rev Cell Mol Biol       Date:  2014       Impact factor: 6.813

8.  Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice.

Authors:  Rikke Stagaard; Carsten Dan Ley; Kasper Almholt; Lisbeth Høier Olsen; Tom Knudsen; Matthew J Flick
Journal:  Blood Adv       Date:  2018-11-27

Review 9.  Plasminogen deficiency.

Authors:  Tiraje Celkan
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

10.  Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice.

Authors:  Annika Jögi; Birgitte Rønø; Ida K Lund; Boye S Nielsen; Michael Ploug; Gunilla Høyer-Hansen; John Rømer; Leif R Lund
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.